caffeine has been researched along with Diabetic Neuropathies in 10 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 74-year-old man who had type 2 diabetes mellitus of a duration of 20 years was admitted for syncope after eating a high carbohydrate meal." | 5.56 | Prevention of postprandial hypotension-related syncope by caffeine in a patient with long-standing diabetes mellitus. ( Furukawa, K; Hanyu, O; Iijima, K; Ishiguro, H; Ito, M; Morikawa, H; Sone, H; Sonoda, K; Suzuki, T, 2020) |
| " The aim of the present investigation was to evaluate, firstly, the peripheral and systemic effects of amitriptyline on tactile allodynia in the streptozotocin (STZ)-induced diabetic rat model of neuropathic pain and, secondly, whether caffeine coadministration affects the actions of amitriptyline." | 3.71 | Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. ( Aslantas, A; Dokmeci, I; Firat, Z; Karadag, HC; Tamer, M; Ulugol, A, 2002) |
| "A 74-year-old man who had type 2 diabetes mellitus of a duration of 20 years was admitted for syncope after eating a high carbohydrate meal." | 1.56 | Prevention of postprandial hypotension-related syncope by caffeine in a patient with long-standing diabetes mellitus. ( Furukawa, K; Hanyu, O; Iijima, K; Ishiguro, H; Ito, M; Morikawa, H; Sone, H; Sonoda, K; Suzuki, T, 2020) |
| "The etiology of painful diabetic neuropathy is poorly understood, but may result from neuronal hyperexcitability secondary to alterations of Ca2+ signaling in sensory neurons." | 1.33 | Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. ( Abatan, O; Larkin, D; Li, F; Obrosova, IG; Stevens, MJ; Stuenkel, EL; Tian, D, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Srivastava, B | 2 |
| Sen, S | 2 |
| Bhakta, S | 1 |
| Sen, K | 2 |
| Abdelkader, NF | 1 |
| Ibrahim, SM | 1 |
| Moustafa, PE | 1 |
| Elbaset, MA | 1 |
| Furukawa, K | 1 |
| Suzuki, T | 1 |
| Ishiguro, H | 1 |
| Morikawa, H | 1 |
| Sonoda, K | 1 |
| Iijima, K | 1 |
| Ito, M | 1 |
| Hanyu, O | 1 |
| Sone, H | 1 |
| Stefanello, N | 1 |
| Schmatz, R | 1 |
| Pereira, LB | 1 |
| Cardoso, AM | 1 |
| Passamonti, S | 1 |
| Spanevello, RM | 1 |
| Thomé, G | 1 |
| de Oliveira, GMT | 1 |
| Kist, LW | 1 |
| Bogo, MR | 1 |
| Morsch, VM | 1 |
| Schetinger, MRC | 1 |
| Ulugol, A | 1 |
| Karadag, HC | 1 |
| Tamer, M | 1 |
| Firat, Z | 1 |
| Aslantas, A | 1 |
| Dokmeci, I | 1 |
| Kruglikov, I | 1 |
| Gryshchenko, O | 1 |
| Shutov, L | 1 |
| Kostyuk, E | 1 |
| Kostyuk, P | 1 |
| Voitenko, N | 1 |
| Li, F | 1 |
| Obrosova, IG | 1 |
| Abatan, O | 1 |
| Tian, D | 1 |
| Larkin, D | 1 |
| Stuenkel, EL | 1 |
| Stevens, MJ | 1 |
| Toh, V | 1 |
| Duncan, E | 1 |
| Lewis, N | 1 |
| Fichter, L | 1 |
| Matthews, DR | 1 |
| Richardson, T | 1 |
| Kerr, D | 1 |
10 other studies available for caffeine and Diabetic Neuropathies
| Article | Year |
|---|---|
Effect of caffeine on the possible amelioration of diabetic neuropathy: A spectroscopic study.
Topics: Blood Glucose; Caffeine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Insulin; Insulin | 2022 |
Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways.
Topics: Animals; Caffeine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperglycemia; Hypoglycem | 2022 |
Prevention of postprandial hypotension-related syncope by caffeine in a patient with long-standing diabetes mellitus.
Topics: Aged; Autonomic Nervous System Diseases; Blood Pressure; Caffeine; Diabetes Mellitus, Type 2; Diabet | 2020 |
Free serum sorbitol and its interaction with caffeine: A suggestive approach for plausible remediation of diabetic neuropathy.
Topics: Caffeine; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathies; Humans; Sorbitol; Spectr | 2022 |
Effects of chlorogenic acid, caffeine and coffee on components of the purinergic system of streptozotocin-induced diabetic rats.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Animals; Blood Platelets; Caffeine; Cerebral Cortex; Chlorogen | 2016 |
Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats.
Topics: Adenosine; Amitriptyline; Analgesics; Animals; Antidepressive Agents, Tricyclic; Caffeine; Diabetes | 2002 |
Diabetes-induced abnormalities in ER calcium mobilization in primary and secondary nociceptive neurons.
Topics: Animals; Caffeine; Calcium; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Endoplasmic Reti | 2004 |
Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Body Weight; Caffeine; Calcium Signaling; Central Ne | 2005 |
Ergotamine use in severe diabetic autonomic neuropathy.
Topics: Aged; Caffeine; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Combinations; Ergotamine; Hum | 2006 |
Ergotamine use in severe diabetic autonomic neuropathy.
Topics: Caffeine; Diabetic Neuropathies; Dietary Supplements; Ergotamine; Humans; Vasoconstrictor Agents | 2007 |